Given the above, our findings indicate that NAF1 depletion in wild-type p53 glioma cells not only can attenuate ribosomal biosynthesis but also reactivate p53 signaling by blocking MDM2-p53 loop, thereby inhibiting malignant phenotypes of glioma cells. Here, MDM2 is linked to central nervous system cancer.